Opioid receptors on white blood cells: Effect of HIV infection and methadone treatment

Pain

Volumn 98, Issue 1-2, 2002, Pages 187-194

  Beck, Martina ^a   Mirmohammadsadegh, Alireza ^a   Franz, Barbara ^a   Blanke, Jörg ^b   Hengge, Ulrich R ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b Rhine State Hospital   (Germany)

Author keywords

Drug abusers; HIV; Immunomodulation; Methadone; Opioid receptor

Indexed keywords

DELTA OPIATE RECEPTOR; METHADONE; POLYCLONAL ANTIBODY;

ADULT; ARTICLE; CELL SELECTION; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FLUORESCENCE; GRANULOCYTE; HOMOSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LEUKOCYTE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MONOCYTE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; HIV INFECTIONS; HUMANS; LEUKOCYTES; METHADONE; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; REFERENCE VALUES; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL LOAD;

EID: 0036291408     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00044-1     Document Type: Article

References (49)

1. Characterization of kappa-opioid receptor transcripts expressed by T cells and macrophages
2. Differential opioid agonist regulation of the mouse mu opioid receptor
3. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception
4. Neutrophil function and opioid receptor expression on leucocytes during chronic naltrexone treatment in humans
5. The effect of methadone on immunological parameters among HIV-positive and HIV-negative drug users
6. Cellular mechanisms involved in morphine-mediated suppression of CTL activity
7. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis
8. Kappa-opioid potentiation of tumor necrosis factor-alpha-induced anti-HIV-1 activity in acutely infected human brain cell cultures
9. Delta opioid receptor gene expression in lymphocytes
10. Mu opioid receptor gene expression in immune cells
11. Conseqences of opiate-dependency in a monkey model of AIDS
12. Opioid modulation of immune responses: Effects on phagocyte and lymphoid cell populations
13. Abolition of morphine immunosuppression in mice lacking the mu-opioid receptor gene
14. Observational analysis of German injecting drug users (IVDU): Survival with and without methadone maintenance treatment
15. Opioid mediated effects on the immune system: Sympathetic nervous system involvement
16. Opiate tolerance and dependence: Receptors, G-proteins, and antiopiates
17. HIV prevalence and risk behavior among injecting drug users who participate in 'low-threshold' methadone programs in Amsterdam
18. Decline of infectious skin manifestations in the HAART era
19. Immunosuppression by morphine is mediated by central pathways
20. Oligomerization of opioid receptors with beta 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation
21. The delta-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization
22. Methadone-induced desensitization of the delta-opioid receptor is mediated by uncoupling of receptor from G protein
23. The difference between methadone and morphine in regulation of delta-opioid receptors underlies the antagonistic effect of methadone on morphine-mediated cellular actions
24. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor
25. Role of increase of opioid receptors in granulocyte CD11b/CD18 dysfunction
26. Granulocyte defects and opioid receptors in chronic exposure to heroin or methadone in humans
27. Expression of functional mu-opioid receptors during T cell development
28. The effects of methadone on immune function among injecting drug users: A review
29. Chemokine signaling and functional responses: The role of receptor dimerization and TK pathway activation
30. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An 18-month prospective follow-up
31. Delta opioid receptor expression is induced by concanavalin A in CD4+ T cells
32. Decreased natural and antibody-dependent cellular cytotoxic activities in intravenous drug abusers
33. Immunoregulatory effects of morphine on human lymphocytes
34. Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients
35. The medical status of methadone maintenance patients in treatment for 11-18 years
36. Opiate effects on in vitro human retroviral infection
37. Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononuclear cells
38. The opioid-cytokine connection
39. Evidence for opioid receptors on cells involved in host defense and the immune system
40. Involvement of brain opiate receptors in the immune-suppressive effect of morphine
41. Decline in HIV-1 seroprevalence and low seroconversion rate among injecting drug users at a methadone maintenance program in New York City
42. Kappa-Opioid receptor in humans: CDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system
43. Evidence for the involvement of opioid neuropeptides in the adherence and migration of immunocompetent invertebrate hemocytes
44. Direct cellular immunomodulation produced by diacetylmorphine (heroin) or methadone
45. Chronic opioid antagonist administration upregulates mu opioid receptor binding without altering mu opioid receptor mRNA levels
46. Human μ opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment
47. Differential expression of opioid receptor genes in human lymphoid cell lines and peripheral blood lymphocytes
48. Central actions of opiates and opioid peptides